Searching News Database: haemophilia B
HSMN NewsFeed - 3 Jul 2020
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
HSMN NewsFeed - 25 Oct 2017
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
HSMN NewsFeed - 11 Mar 2009
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
